Treatment and prevention of rickettsial and ehrlichial infections

Dermatologic Therapy

Volumn 17, Issue 6, 2004, Pages 499-504

  Maender, Jennifer L ^a   Tyring, Stephen K ^b,c  

^a St Joseph's Medical Center Houston   (United States)

^b UNIVERSITY OF TEXAS   (United States)

^c CENTER FOR CLINICAL STUDIES   (United States)

Author keywords

Arthropods; Ehrlichia; Rickettsia; Spotted fevers

Indexed keywords

CHLORAMPHENICOL; DOXYCYCLINE; RIFAMPICIN; TETRACYCLINE;

AGE DISTRIBUTION; BACTERIAL INFECTION; BONE DISEASE; BONE GROWTH; DIARRHEA; DIFFERENTIAL DIAGNOSIS; DRUG BIOAVAILABILITY; DRUG EXCRETION; DRUG HALF LIFE; EHRLICHIOSIS; ENAMEL HYPOPLASIA; FEVER; GASTROINTESTINAL SYMPTOM; GRAY BABY SYNDROME; HUMAN; NAUSEA; NEWBORN DISEASE; PREGNANT WOMAN; REVIEW; RICKETTSIOSIS; ROCKY MOUNTAIN SPOTTED FEVER; SCRUB TYPHUS; SIDE EFFECT; SKIN BIOPSY; TYPHUS; VOMITING;

ANIMALS; ANTI-BACTERIAL AGENTS; DOXYCYCLINE; EHRLICHIA; EHRLICHIOSIS; HUMANS; RICKETTSIA; RICKETTSIA INFECTIONS;

EID: 10844236216     PISSN: 13960296     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1396-0296.2004.04052.x     Document Type: Review

References (29)

1. Austin FE, Winkler HH. Relationship of rickettsial physiology and composition to the Rickettsia-host cell interaction. In: Walker DH, ed. Biology of Rickettsial Diseases. Boca Raton, FL: CRC Press, 1988: 29-49.
2. Harrell GT, Aikawa JK. Pathogenesis of circulatory failure in Rocky Mountain spotted fever. Alteration in the blood volume and the thiocyanate space at various stages of the disease. Arch Intern Med 1949: 83: 331-347.
3. Walker DH, Crawford CG, Cain BG. Rickettsial infection of the pulmonary microcirculation: the basis for interstitial pneumonitis in Rocky Mountain spotted fever. Hum Pathol 1980: 11: 263-272.
4. Walker DH, Mattern WD. Acute renal failure in Rocky Mountain spotted fever. Arch Intern Med 1979: 139: 443-448.
5. Dumler JS, Barbet AF, Bekker CP, et al. Reorganization of genera in the families Rickettsiaceae and Anaplasmataceae in the order Rickettsiales: unification of some species of Ehrlichia with Anaplasma, Cowdria with Ehrlichia and Ehrlichia with Neorickettsia, descriptions of six new species combinations and designation of Ehrlichia equi and HGE agent as subjective synonyms of Ehrlichia phagocytophila. Int J Syst Evol Microbiol 2001: 51: 2145-2165.
6. Paddock CD, Childs JE. Ehrlichia chaffeensis: a prototypical emerging pathogen. Clin Microbiol Rev 2003: 16 (1): 37-64.
7. Myers SA, Sexton D. Dermatologic manifestations of arthropod-borne diseases. Infect Dis Clin North Am 1994: 8: 689-712.
8. Rose H. The clinical manifestations and laboratory diagnosis of rickettsialpox. Ann Intern Med 1949: 31: 871-883.
9. Massey E, Thames T, Coffey C, Gallis H. Neurologic complications of Rocky Mountain spotted fever. South Med J 1985: 78: 1288-1290.
10. Randall MB, Walker DH. Rocky Mountain spotted fever: gastrointestinal and pancreatic lesions and rickettsial infection. Arch Pathol Laboratory Med 1984: 108: 963-967.
11. Kass EM, Szaniawski WK, Levy H, Leach J, Srinivasan K, Rives C. Rickettsialpox in a New York City hospital, 1980-1989. N Engl J Med 1994: 331: 1612-1617.
12. Baxter JD. The typhus group. Clin Dermatol 1996: 14: 271-278.
13. Berman S, Kundin W. Scrub typhus in South Vietnam, a study of 87 cases. Ann Intern Med 1973: 79: 26-30.
14. Dumler JS, Taylor JP, Walker DH. Clinical and laboratory features of murine typhus in South Texas, 1980 through 1987. JAMA 1991: 266: 1365-1370.
15. Jacobs RF. Human monocytic ehrlichiosis: similar to Rocky Mountain spotted fever but different. Pediatr Ann 2002: 31 (3): 180-184.
16. Olano JP, Walker DH. Human ehrlichioses. Med Clin North Am 2002: 86 (2): 375-392.
17. Paddock CD, Folk SM, Shore GM, et al. Infections with Ehrlichia chaffeensis and Ehrlichia ewingii in persons coinfected with human immunodeficiency virus. Clin Infect Dis 2001: 33 (9): 1586-1594.
18. Kelly DJ, Chan CT, Paxton H, Thompson K, Howard R, Dasch GA. Comparative evaluation of a commercial enzyme immunoassay for the detection of human antibody to Rickettsia typhi. Clin Diagn Laboratory Immunol 1995: 2: 356-360.
19. Kelly DL, Wong PW, Can E, Lewis GE Jr. Comparative evaluation of the serodiagnosis of rickettsial disease. Am J Trop Med 1988: 38: 400-406.
20. Walker D, Burday M, Folds J. Laboratory diagnosis of Rocky Mountain spotted fever. South Med J 1980: 73: 1443-1446.
21. Donovan BJ, Weber DJ, Rublein JC, Raasch RH. Treatment of tick-borne diseases. Ann Pharmacother 2002: 36 (10): 1590-1597.
22. Holman RC, Paddock CD, Curns AT, Krebs JW, McQuiston JH, Childs JE. Analysis of risk factors for fatal Rocky Mountain spotted fever: evidence for superiority of tetracyclines for therapy. J Infect Dis 2001: 184 (11): 1437-1444.
23. Raoult D, Drancourt M. Antimicrobial therapy of rickettsial diseases. Antimicrob Agents Chemother 1991: 35: 2457-2462.
24. Krause PJ, Corrow CL, Bakken JS. Successful treatment of human granulocytic ehrlichiosis in children using rifampin. Pediatrics 2003: 112: e252-3.
25. Smilack JD. The tetracyclines. Mayo Clin Proc 1999: 74 (7): 727-729.
26. Purvis J, Edwards M. Doxycycline use for rickettsial disease in pediatric patients. Pediatr Infect Dis J 2000: 19: 871-874.
27. Amstey MS. Chloramphenicol therapy in pregnancy. Clin Infect Dis 2000: 30 (1): 237.
28. Twartz JC, Shirai A, Selvaraju G, Saunders JP, Huxsoll DL, Groves MG. Doxycycline prophylaxis for human scrub typhus. J Infect Dis 1982: 146: 811-818.
29. Olson JG, Bourgeois AL, Fang RC, Coolbaugh JC, Dennis DT. Prevention of scrub typhus: prophylactic administration of doxycycline in a randomized double-blind trial. Am J Trop Med 1980: 29: 989-997.